Research Articles
High-Negative Anti–Helicobacter pylori IgG Antibody Titers and Long-Term Risk of Gastric Cancer: Results from a Large-Scale Population-Based Cohort Study in Japan
Manami Inoue, Norie Sawada, Atsushi Goto, Taichi Shimazu, Taiki Yamaji, Motoki Iwasaki and Shoichiro Tsugane; for the JPHC Study Group
Manami Inoue
Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Norie Sawada
Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Atsushi Goto
Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Taichi Shimazu
Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Taiki Yamaji
Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Motoki Iwasaki
Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Shoichiro Tsugane
Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
DOI: 10.1158/1055-9965.EPI-19-0993 Published February 2020

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
February 2020
Volume 29, Issue 2
Volume 29, Issue 2
High-Negative Anti–Helicobacter pylori IgG Antibody Titers and Long-Term Risk of Gastric Cancer: Results from a Large-Scale Population-Based Cohort Study in Japan
Manami Inoue, Norie Sawada, Atsushi Goto, Taichi Shimazu, Taiki Yamaji, Motoki Iwasaki and Shoichiro Tsugane for the JPHC Study Group
Cancer Epidemiol Biomarkers Prev February 1 2020 (29) (2) 420-426; DOI: 10.1158/1055-9965.EPI-19-0993
High-Negative Anti–Helicobacter pylori IgG Antibody Titers and Long-Term Risk of Gastric Cancer: Results from a Large-Scale Population-Based Cohort Study in Japan
Manami Inoue, Norie Sawada, Atsushi Goto, Taichi Shimazu, Taiki Yamaji, Motoki Iwasaki and Shoichiro Tsugane for the JPHC Study Group
Cancer Epidemiol Biomarkers Prev February 1 2020 (29) (2) 420-426; DOI: 10.1158/1055-9965.EPI-19-0993
Jump to section
Advertisement